To date, the company has raised capital from strategic investors. We are now seeking to raise additional funds to progress the clinical development of our lead candidate.
If you are an Accredited Investor and are interested in learning more about investment opportunities with Soricimed Biopharma, please contact us.
Corporate and Clinical Development Timelines
We are seeking additional capital to continue our clinical development of SOR-C13 and advance our Peptide-Drug Conjugate program.
To date, we have been financed by high net worth individuals and angel investors.
If you would like to learn more about the investment potential of Soricimed Biopharma Inc., please fill out the form at the top of the page.
Address
18 Botsford St., Suite 201
Moncton, N.B. E1C 4W7
Canada
T: 506.856.0400
F: 506.856.0414
E: info@soricimed.com
© Copyright 2023 Soricimed Biopharma